Gold nanoparticle imaging boosts cancer treatment
Gold nanoparticles (AuNPs) have emerged as promising drug carriers for cancer therapy and targeted drug delivery but tracking them has been challenging.

Traditional imaging methods often involve tracers like fluorescent dyes and radioisotopes, which give limited visualisation and inaccurate results due to detachment from AuNPs.
Now, researchers from Waseda University in Japan have introduced a new imaging technique that uses neutron activation to transform stable gold into a radioisotope of gold that enables long-term tracking of the AuNPs within the body.
The study was led by Nanase Koshikawa, a PhD student in the Graduate School of Advanced Science and Engineering at Waseda University, and Jun Kataoka, a Professor in the Faculty of Science and Engineering at Waseda University, in collaboration with Osaka University and Kyoto University. The findings of this study are published in Applied Physics Letters.
“Traditional imaging methods involve external tracers, which may detach during circulation,” Koshikawa said in a statement. “To overcome this limitation, we directly altered the AuNPs, making them detectable via X-rays and gamma rays without the use of external tracers.”
Register now to continue reading
Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.
Benefits of registering
-
In-depth insights and coverage of key emerging trends
-
Unrestricted access to special reports throughout the year
-
Daily technology news delivered straight to your inbox
Experts speculate over cause of Iberian power outages
The EU and UK will be moving towards using Grid Forming inverters with Energy Storage that has an inherent ability to act as a source of Infinite...